MA
64
7
DFS
64
2
AON
54
2
JWN
48
6
AA
48
-12
COF
60
2
VRSN
53
-4
WY
54
4
NOC
43
11
ROK
62
15
TXT
55
3
FTI
81
5
RIG
60
2
MET
72
5
CMG
72
5
HPQ
63
6
EBAY
47
4
SCHW
62
-2
DD
63
3
GE
67
2
MA
64
7
DFS
64
2
AON
54
2
JWN
48
6
AA
48
-12
COF
60
2
VRSN
53
-4
WY
54
4
NOC
43
11
ROK
62
15
TXT
55
3
FTI
81
5
RIG
60
2
MET
72
5
CMG
72
5
HPQ
63
6
EBAY
47
4
SCHW
62
-2
DD
63
3
GE
67
2
Financhill
Back

Regenxbio Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
26

RGNX
Regenxbio

Last Price:
9.60
Seasonality Move:
-5.7%
Buy
61

EYPT
EyePoint Pharmaceuticals

Last Price:
8.94
Seasonality Move:
28.93%
Sell
26
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.59. The Score for RGNX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.95. The Score for EYPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight buying pressure.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 46.66 Sell
Chaikin Money Flow: 300118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.94 - 10.6) Sell
Bollinger Bands (100): (9.84 - 12.8) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 41.34 Sell
Chaikin Money Flow: 378625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.4 - 11.84) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.95 Sell
20-day SMA: 9.79 Sell
50-day SMA: 10.29 Sell
200-day SMA: 14.24 Sell
8-day EMA: 9.79 Sell
20-day EMA: 9.92 Sell
50-day EMA: 10.36 Sell
200-day EMA: 13.18 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.31 Sell
20-day SMA: 10.76 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.45 Sell
8-day EMA: 9.35 Sell
20-day EMA: 10.02 Sell
50-day EMA: 9.94 Sell
200-day EMA: 11.46 Sell

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):